Skip to main content

DA32 Life Science Tech Acquisition Corp. (DALS)

NASDAQ: DALS · IEX Real-Time Price · USD
9.72 -0.02 (-0.21%)
Oct 19, 2021 12:49 PM EDT - Market open

Company Description

DA32 Life Science Tech Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

In coming together as co-sponsors of DA32, Deerfield Management, ARCH Venture Partners and Section 32 aim to leverage their complementary capabilities and networks in order to acquire, merge with and grow a promising life science technology opportunity.

We intend to focus our search for business combination targets in four separate areas of the larger life sciences industry, including: Life Sciences Tools, Diagnostics, Synthetic Biology, and Data and Analytics Platforms.

DA32 Life Science Tech Acquisition Corp.
CountryUnited States
Founded2021
IPO DateJul 28, 2021
IndustryShell Companies
SectorFinancial Services
Employees2,021
CEOSteve Kafka

Contact Details

Address:
345 Park Avenue South, 12th Floor
New York, NY 10010
United States
Phone212-551-1600

Stock Details

Ticker SymbolDALS
ExchangeNASDAQ
Reporting CurrencyUS Dollars
IPO Price$10.00
CIK Code1863294
ISIN NumberUS23312M1062
Employer ID86-3352988

Key Executives

NamePosition
Dr. Steven Kafka Ph.D.Chief Executive Officer and Director
Christopher E. WolfeChief Financial Officer and Secretary